在英国男性中使用丸激素替代疗法的经验和结果的横截面调查
Austen El-Osta1, Vivian N Liu2, David Huang2
1Self-Care Academic Research Unit (SCARU), School of Public Health, Imperial College London, London, UK.
Translational andrology and urology
|June 18, 2025
概括
许多患有丸激素缺乏症 (TD) 的男性推迟治疗,尤其是老年人. 替代疗法 (TRT) 是非常有效的,改善生活质量,但需要提高意识和获取.
科学领域:
- 内分泌学 在内分泌学.
- 男人的健康 男人的健康
- 安德罗学与人类学
背景情况:
- 晚期出现的缺乏症 (TD) 影响6-30%的男性,替代疗法 (TRT) 提供改善情绪和骨密度等好处.
- 了解患者对TD和TRT的体验对于优化护理和解决治疗障碍至关重要.
研究的目的:
- 调查TD男性关于低丸激素和TRT的个人经验.
- 识别进入TRT的障碍,了解患者的动机和期望.
主要方法:
- 通过来自诊所,专业组织和研究网络的电子邮件列表招募TRT用户.
- 在Qualtrics XM上进行了52项问卷调查,以收集有关感知,症状和生活质量的数据.
- 利用后勤回归来分析人口统计,症状持续时间和治疗有效性之间的关联.
主要成果:
- 86%的男性推迟了TRT至少一年;年长的男性 (51+) 更有可能推迟.
- 85%的人认为TRT有效或非常有效,长期使用者报告更高的满意度.
- 接受TRT的关键动机包括改善关系 (79%) 和外表 (53%);常见的副作用包括和丸收缩.
结论:
- 在寻求治疗之前,大量50岁以上的男性经历了长期的TD症状.
- 需要提高对TD症状的认识和教育.
- 简化及时和公平地获得有效的TRT对于改善男性健康结果至关重要.
更多相关视频
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.5K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.3K
相关概念视频
Disorders of the Male Reproductive System
617
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
617
Testosterone: Functions and Regulation
1.1K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.1K
Infertility in Males
339
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
339
Menopause
269
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
269
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
